Company Description
Novo Nordisk can tell diabetics where to stick it. One of the world's leading producers of insulin, Novo Nordisk also makes insulin analogues,...
Key Novo Nordisk Financials
| Company Type | Public - NYSE: NVO; Copenhagen: NOVO B Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $8,261.6 |
| 2007 Employees | 26,000 |
More Novo Nordisk Financials (11 pages)
Latest Novo Nordisk Jobs jobs by Indeed
Rankings
- #229 in FT Global 500
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Novo Nordisk's competition across multiple industries
Top Novo Nordisk Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Novo Nordisk Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Sten Scheibye | Network | E-mail |
| President and CEO | Lars Rebien Sørensen | Network | E-mail |
| EVP and CFO | Jesper Brandgaard | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Novo Nordisk News
- Michael J. Fox Foundation Awards Grant To Depomed [InvesTrend] (23 Jul 2008 00:01:00 EDT)
- MIXTURES OF PEGYLATED INSULIN AND FAST ACTING INSULIN FOR PULMONARY ADMINISTRATION [PCT Biblio Info] (22 Jul 2008 14:03:00 EDT)
- UREA GLUCOKINASE ACTIVATORS [PCT Biblio Info] (22 Jul 2008 14:03:00 EDT)